PatentsIndia
Delhi High Court Allows Dr. Reddy’s to Continue Exporting Semaglutide Amid Patent Dispute with Novo Nordisk
The Delhi High Court refused Novo Nordisk’s plea for an interim injunction against Dr. Reddy’s Laboratories over alleged infringement of Indian Patent No. 262697 related to Semaglutide. The Court found the patent prima facie vulnerable to revocation challenges based on prior claiming and lack of inventive step, allowi…
Tuesday, December 23, 2025